PT Kimia Farma (Persero) Tbk Class B · IDX:KAEF
PT Kimia Farma (Persero) Tbk Class B — PT Kimia Farma — Q2 2020 Earnings Presentation
34 slides from PT Kimia Farma (Persero) Tbk Class B's earnings presentation, 2020
Slide 1: Company Update PT Kimia Farma Tbk
Company Update PT Kimia Farma Tbk Q2 – 2020 Healthy Growth Performance
Slide 2: Speaker
Speaker Mr. Pardiman Finance Director PT Kimia Farma Tbk (KAEF) Indonesian Citizen Education & Training: Master of Management from Diponegoro University Bachelor of Economics Management from Diponegoro University BUMN Executive Leadership Program IFA Strategic Forum Employment Histor
Slide 3: Agenda
Agenda 1 MARKET OVERVIEW 2 COMPANY OVERVIEW 3 FINANCIAL HIGHLIGHT 4 BUSINESS EXPANSION & INVESTMENT 5 OUR RETAIL BUSINESS-KIMIA FARMA APOTEK
Slide 4: Market Overview
1 MARKET OVERVIEW
Slide 5: Indonesia Pharmaceutical Market (Q2/2020)
Indonesia Pharmaceutical Market (Q2/2020) Indonesia pharmaceutical market decrease at -1.0% in MAT Q2/2020 • Ethical Branded still growth 1.2% and 100,000 9 Free Sales growth 0.9% in MAT 90,000 8.0 8 MNC ETHICAL Q2/2020, but for the Unbranded 7 BRANDED, 80,000 21,983 DOMESTIC Generic decrease -9.8%.
Slide 6: Channel Value Share in Indonesia (2Q/2020)
Channel Value Share in Indonesia (2Q/2020) Hospital channel has decreased both for MNC and Domestic Company, while in Pharmacy channel, the growth was driven by Domestic Company in MAT Q2 2020. MAT Q2 2020 VALUE SHARE (PHARMACY, HOSPITAL, DRUGSTORE) – HNA PRICE Growth 0.9% -2.5% -2.5% -0.5% 0% 0% 7%
Slide 7: Company Overview
2 COMPANY OVERVIEW
Slide 8: Corporate Structure
Corporate Structure * December 31, 2019 * June 30, 2020 90.025% 9.975% 90.025% 1 Share Seri A 9.975% Government Public PT Bio Farma Dwiwarna Public (Persero) Government 2003 2003 2011 2014 2016 2018 2019 KF : 99.99% KF : 99.99% KF : 51.00% KF : 10.00% KF : 80.67% KF : 60.00% KF : 56.77% KFA: 0.01% Y
Slide 9: Top 20 Pharmaceutical Industry in Indonesia (2Q/2020)
Top 20 Pharmaceutical Industry in Indonesia (2Q/2020) MAT Rank Top 20 Companies Share% Growth% + 1,133 315 1 DEXA MEDICA ,374 2.374 5.9 -5.5 (2.8%) (0.8%) 2 SANBE 2.305 2,305 5.7 -4.1 3 KALBE FARMA 1.956 1,956 4.9 -17.0 4 NOVELL PHARM 1.190 1,190 3.0 -4.0 1,448 (3.6%) 4 5 KIMIA FARMA 1.133 1,133 2.8
Slide 10: Integrated Business Chain
Integrated Business Chain Manufacture of National Clinic & Clinical Production Trading & Customer Active Pharmaceutical Distribution Center Retail Pharmacy Laboratory Facility Distribution Ingredients (API) (NDC) *June 30, 2020 Unit Usaha Sumatera, Bali, Nusa Sulawesi, Jawa Kalimantan Total Business
Slide 11: Company Products & Composition Q2/2020
Company Products & Composition Q2/2020 Q2/2019 Generics Ethical Cosmetics OTC & Herbal 47.29% Cosmetics Ethical 15.29% 23.18% OTC & Herbal 8.50% Export Medical API 1.00% Devices 4.74% 0.00% Q2/2020 Generic Generic API Medical Device 49.56% Cosmetics Ethical 7.77% 20.94% OTC & Herbal Medical 10.99% D
Slide 12: Covid-19 Health and Safety Audits
Covid–19 Health and Safety Audits COVID-19 will change business even after the pandemic ends and it is unlikely that everything will return to “NORMAL“ and now we are entering the “NEW NORMAL” era. Business will face signifcant calllenges in protecting the “SAFE GUARD Employee and Stakeholders o
Slide 13: Certification
Certification Good Manufacturing Practice Good Traditional Medicine Good API Plant Watudakon, Medan, Bandung, Manufacturing Practice Manufacturing Practice Jakarta Plant Bandung, Jakarta Plant Kina (SIL) Good Distribution Practice ISO 9001: 2008 ISO 9001: 2015 (GDP) Plant Jakarta, Bandung, Plant Sem
Slide 14: Award
Award Top Brand Award Musium Rekor Indonesia IICD Corporate 3 Awards from Top Brand for: (MURI) Governance Award Enkasari (Sprue Medicine), Salycil (Health TOP 50 Company Corporate The most of the use of mouthwash Powder), Asifit products (the category of Governance Award 2019 with participants simu
Slide 15: Long Term Plan Strategy 2020 – 2024
Long Term Plan Strategy 2020 – 2024 2024 2023 2022 • Global network and 2021 product expansion Household name for 2020 Additional capacity health and beauty and products at KFSP herbal products Addition of BBO BBO Import reduction Becoming one of the Retail Transformation Factory Facilit
Slide 16: Strategic Initiatives 2020
Strategic Initiatives 2020 INTEGRATED HEALTHCARE ECOSYSTEM With a complete business portfolio (end to end) Kimia Farma is committed to creating integrated health services 1 OPERATIONAL EXCELLENCE Strengthening the entire value chain business in Kimia Farma Group with its main goal is that the proces
Slide 17: Financial Highlights
3 FINANCIAL HIGHLIGHTS
Slide 18: Peer Performance Q2/2020
Peer Performance Q2/2020 45,00 40,00 38,05 Peers Growth (2Q/2020) 35,00 25,00 21,28 30,00 26,11 20,00 25,00 15,00 20,00 10,00 3,60 3,81 3,52 5,00 1,56 15,00 0,17 - 10,00 5,44 6,70 -0,11 3,60 -5,00 5,00 -10,00 0,00 3,10 -10,72 -15,00 -17,78 -5,00 -1,50 -1,00 -20,00 2017 2018 2019 Q2/2020 KAEF KLBF TS
Slide 19: Financial Performance Q2/2020
Financial Performance Q2/2020 REVENUE OPERATING PROFIT EBITDA In IDR billion In IDR billion In IDR billion 365,034 365.034 4,687,803 4.687.803 496.729 496,729 296,302 296.302 394.502 394,502 23.20% 25.91% 4.524.819 4,524,819 3.60% Q2 2019 Q2 2020 Q2 2019 Q2 2020 Q2 2019 Q2 2020 ASSETS LIABILITIES EQ
Slide 20: Financial Performance Q2/2020
Financial Performance Q2/2020 EBITDA MARGIN ROI 10,60% 10.60% 2,14% 2.14% 8.72% 8,72% 1.93% 1,93% Q2 2019 Q2 2020 Q2 2019 Q2 2020 ROE ROA 0,85% 0.85% 0,28% 0.28% 0.28% 0,28% 0,68% 0.68% Q2 2019 Q2 2020 Q2 2019 Q2 2020 27
Slide 21: Business Expansion & Investment
4 BUSINESS EXPANSION & INVESTMENT
Slide 22: Business Expansion & Investment: Capex 2017-2020
Business Expansion & Investment CAPEX 2017 - 2020 In IDR Billion Banjaran Plant Rapid Test Plant API & HFC Plant Acquisition of 2,140 2.140 PT Phapros Tbk 1.352 1,352 788 546 * Kimia Farma Dawaa Injection Prod. Distribution (KFTD) SAP, QR Code, Track (Saudi Arabia) Facility Renovation & Trace, and I
Slide 23: Our Retail Business-Kimia Farma Apotek
5 OUR RETAIL BUSINESS-KIMIA FARMA APOTEK
Slide 24: Integrated Healthcare Network
Integrated Healthcare Network Sulawesi, Bali ,Nusa Kimia Farma Apotek has a fully integrated, seamless Services Sumatera Jawa Kalimantan Tenggara Maluku, Total Papua healthcare network covering all 34 provinces in Indonesia – APOTEKS 217 667 130 121 173 1,308 cementing its position as the biggest up
Slide 25: Kimia Farma Apotek – Our Retail Side
Kimia Farma Apotek – Our Retail Side HISTORY OUR PRODUCTS • 468 Klinik Pratama & Utama • Clinic Managed Care • BPJS Network Provider (open provider) • Vaccination Services with No. of International Certified employees • 1.308 Pharmacy • Dental clinic service > 9000 • Haemodialysis clinic • Standard
Slide 26: Financial Performance Q2/2020
Financial Performance Q2/2020 REVENUE OPERATING PROFIT EBITDA In IDR billion 2.723.725 2,723,725 In IDR billion In IDR billion 105,669 105.669 225,789 225.789 76,010 76.010 2,411,928 2.411.928 39.20% 147.02% 91.405 91,405 12.93% Q2 2019 Q2 2020 Q2 2019 Q2 2020 Q2 2019 Q2 2020 ASSETS LIABILITIES EQUI
Slide 27: Financial Performance Q2/2020
Financial Performance Q2/2020 EBITDA MARGIN ROI 8,29% 8.29% 3,36% 3.36% 2,54% 2.54% 3,79% 3.79% Q2 2019 Q2 2020 Q2 2019 Q2 2020 ROE ROA 5,02% 5.02% 5.07% 5,07% 1,46% 1.46% 1,27% 1.27% Q2 2019 Q2 2020 Q2 2019 Q2 2020 36
Slide 28: Kimia Farma Apotek - Digital Development Roadmap
Kimia Farma Apotek - Digital Development Roadmap 2020 2021 2022 2023 2024 Pulverizing Seeding Watering Fertilizing Harvesting Digitization to accelerate Explore new business models and Scaling up business growth through Transform, manage, boost and Subsidiarizing and Going Beyond and optimize busine
Slide 29: Kimia Farma Apotek Digitalization
Kimia Farma Apotek Digitalization • 34 provinces of Indonesia • 1,318 outlets (pharmacies & optics) • 486 clinics (managed by KFD) • 70 laboratories (managed by KFD) Outlets: • 3 beauty clinics • POS for pharmacies • Online channels: 1,254 pharmacies • Sistem Klinik • Integrated with BPJS-PCare: 9 c
Slide 30: Kimia Farma Mobile
Kimia Farma Mobile As a Integrated Healthcare SOE, we keep transforming our service quality; in 16 August 2020, we launched Kimia Farma Mobile, our mobile app services – accessible anywhere and anytime Ease of Access Online Consultation Anytime, Anywhere With our top pharmacists & physicians OMNI Ch
Slide 31: Kimia Farma Drive-Thru
Kimia Farma Drive-Thru Our new breakthrough – the first EVER drive thru pharmacy in Indonesia Where? Apotek Kimia Farma 11 Supratman Bandung Jl. Supratman NO. 72, Kota Bandung. Why? 1. To combat the COVID-19 pandemic by helping people follow the strict healthcare protocol for physical distancing 2.
Slide 32: Kimia Farma and the COVID-19 Pandemic: Mobile Lab PCR
Kimia Farma and the COVID-19 Pandemic: Mobile Lab PCR Kimia Farma Diagnostika will expand the reach of our COVID-19 PCR test to even more people and more area in Indonesia, by making it mobile. By the end of 2020, five PCR Mobile Lab Unit will be opened in 5 cities: Surabaya, Denpasar, Banjarmasin,
Slide 33: Kimia Farma for Indonesia
Kimia Farma for Indonesia National Independence Real Action For Indonesia Equality In Health Distribution With the facility of Active Pharmaceutical Ingredients (API) Supporting the Government as the Kimia Farma supports Kimia Farma encourages the only pharmaceutical industry that the availability o
Slide 34: Terima Kasih Semoga Sehat Selalu
Terima Kasih Semoga Sehat Selalu KANTOR PUSAT Jl. Veteran No. 9 Jakarta Pusat 10110 Phone: +62 21 3847709 | Fax: +62 21 3814441 Email: corsec@kimiafarma.co.id Website: www.kimiafarma.co.id